Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks.

Menniti FS, Lindsley CW, Conn PJ, Pandit J, Zagouras P, Volkmann RA.

Curr Top Med Chem. 2013;13(1):26-54. Review.

2.

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.

Soares HD, Potter WZ, Pickering E, Kuhn M, Immermann FW, Shera DM, Ferm M, Dean RA, Simon AJ, Swenson F, Siuciak JA, Kaplow J, Thambisetty M, Zagouras P, Koroshetz WJ, Wan HI, Trojanowski JQ, Shaw LM; Biomarkers Consortium Alzheimer's Disease Plasma Proteomics Project.

Arch Neurol. 2012 Oct;69(10):1310-7.

3.

Molecular characterization of novel and selective peroxisome proliferator-activated receptor alpha agonists with robust hypolipidemic activity in vivo.

Kane CD, Stevens KA, Fischer JE, Haghpassand M, Royer LJ, Aldinger C, Landschulz KT, Zagouras P, Bagley SW, Hada W, Dullea R, Hayward CM, Francone OL.

Mol Pharmacol. 2009 Feb;75(2):296-306. doi: 10.1124/mol.108.051656. Epub 2008 Oct 29.

PMID:
18971326
4.

Validation of rat reference genes for improved quantitative gene expression analysis using low density arrays.

Cai JH, Deng S, Kumpf SW, Lee PA, Zagouras P, Ryan A, Gallagher DS.

Biotechniques. 2007 Apr;42(4):503-12.

5.

Kinetic analysis of genomewide gene expression reveals molecule circuitries that control T cell activation and Th1/2 differentiation.

Lu B, Zagouras P, Fischer JE, Lu J, Li B, Flavell RA.

Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3023-8. Epub 2004 Feb 20.

6.

Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.

Changelian PS, Flanagan ME, Ball DJ, Kent CR, Magnuson KS, Martin WH, Rizzuti BJ, Sawyer PS, Perry BD, Brissette WH, McCurdy SP, Kudlacz EM, Conklyn MJ, Elliott EA, Koslov ER, Fisher MB, Strelevitz TJ, Yoon K, Whipple DA, Sun J, Munchhof MJ, Doty JL, Casavant JM, Blumenkopf TA, Hines M, Brown MF, Lillie BM, Subramanyam C, Shang-Poa C, Milici AJ, Beckius GE, Moyer JD, Su C, Woodworth TG, Gaweco AS, Beals CR, Littman BH, Fisher DA, Smith JF, Zagouras P, Magna HA, Saltarelli MJ, Johnson KS, Nelms LF, Des Etages SG, Hayes LS, Kawabata TT, Finco-Kent D, Baker DL, Larson M, Si MS, Paniagua R, Higgins J, Holm B, Reitz B, Zhou YJ, Morris RE, O'Shea JJ, Borie DC.

Science. 2003 Oct 31;302(5646):875-8.

7.

Gene array and protein expression profiles suggest post-transcriptional regulation during CD8+ T cell differentiation.

Cham CM, Xu H, O'Keefe JP, Rivas FV, Zagouras P, Gajewski TF.

J Biol Chem. 2003 May 9;278(19):17044-52. Epub 2003 Feb 11.

8.

Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration.

Ang E, Chen J, Zagouras P, Magna H, Holland J, Schaeffer E, Nestler EJ.

J Neurochem. 2001 Oct;79(1):221-4.

9.

Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2.

Capobianco AJ, Zagouras P, Blaumueller CM, Artavanis-Tsakonas S, Bishop JM.

Mol Cell Biol. 1997 Nov;17(11):6265-73.

10.

Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane.

Blaumueller CM, Qi H, Zagouras P, Artavanis-Tsakonas S.

Cell. 1997 Jul 25;90(2):281-91.

11.

Alterations in Notch signaling in neoplastic lesions of the human cervix.

Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML, Artavanis-Tsakonas S.

Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6414-8.

13.
14.

A fusion-defective mutant of the vesicular stomatitis virus glycoprotein.

Whitt MA, Zagouras P, Crise B, Rose JK.

J Virol. 1990 Oct;64(10):4907-13.

15.
16.

Oligomerization of glycolipid-anchored and soluble forms of the vesicular stomatitis virus glycoprotein.

Crise B, Ruusala A, Zagouras P, Shaw A, Rose JK.

J Virol. 1989 Dec;63(12):5328-33.

Supplemental Content

Loading ...
Support Center